DOBMEIER ERIC
SEC insider (Form 3/4/5 filer). CIK 0001202785. Director at Structure Therapeutics Inc. (GPCR) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in WALTHAM, MA.
Companies DOBMEIER ERIC has filed insider reports for
- Structure Therapeutics Inc. (GPCR): Director
- Janux Therapeutics, Inc. (JANX): Director
- Jade Biosciences, Inc. (JBIO): Director
DOBMEIER ERIC
CIK: 0001202785
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 17, 2026GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
39.5K shares- - Jun 11, 2026JANX
Janux Therapeutics, Inc.
AwardDirect5.5K shares- - Jun 9, 2026JBIO
Jade Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
34.8K shares- - Jun 23, 2025GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
51.8K shares- - Jun 11, 2025JANX
Janux Therapeutics, Inc.
AwardDirect3.8K shares- - Apr 29, 2025JBIO
Jade Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
23K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 39,453 | - | - | Direct |
| Jun 11, 2026 |  JANX Janux Therapeutics, Inc. | Award | 5,500 | - | $0 | Direct |
| Jun 9, 2026 |  JBIO Jade Biosciences, Inc. | Award Stock Option (Right to Buy) | 34,843 | - | - | Direct |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 51,804 | - | - | Direct |
| Jun 11, 2025 | JANX Janux Therapeutics, Inc. | Award | 3,750 | - | - | Direct |
| Apr 29, 2025 | JBIO Jade Biosciences, Inc. | Award Stock Option (Right to Buy) | 23,017 | - | - | Direct |
1-6 of 6 transactions